{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:53:22Z","timestamp":1791287602779,"version":"4.1.0"},"reference-count":94,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Pancreatic ductal adenocarcinoma (PDAC) develops within a dense, poorly perfused tumor microenvironment (TME) in which cancer-associated fibroblasts (CAFs) are prominent cellular and structural components. Once viewed as a uniform population of activated matrix-producing cells, CAFs now include myofibroblastic, inflammatory, antigen-presenting and other populations identified by single-cell and spatial studies. These categories sharpen experimental resolution but do not form a stable hierarchy. CAF phenotypes overlap across spatial niches and disease stages, and they change under metabolic stress or treatment. We frame this heterogeneity as a set of context-dependent functional states. This review synthesizes evidence on fibroblast origins, canonical and recently reported states, and the signals that drive state transitions. It then examines CAF functions in extracellular matrix organization, tumor-cell plasticity and dissemination, metabolic support and immune regulation. Findings on tumor-restraining fibroblasts and protective collagen pools challenge indiscriminate stromal depletion. We also assess CAF states as prognostic and predictive biomarkers, their roles in treatment resistance and therapeutic strategies based on depletion, pathway blockade or stromal normalization. Failures of Hedgehog and hyaluronan-directed therapies show that target abundance alone cannot select patients. Clinical translation will require state definitions that integrate function, spatial context and treatment history, supported by reproducible markers, prospective validation and models that retain human stromal diversity.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1971880","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:17:02Z","timestamp":1791285422000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["From CAF subtypes to clinically relevant states: cancer-associated fibroblasts in pancreatic ductal adenocarcinoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Yi","family":"Hao","sequence":"first","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyang","family":"Du","sequence":"additional","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaopeng","family":"Li","sequence":"additional","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-031621-024600","article-title":"Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance","volume":"18","author":"Sherman","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.09.022","article-title":"Spatially confined sub-tumor microenvironments in pancreatic cancer","volume":"184","author":"Gr\u00fcnwald","year":"2021","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01134-8","article-title":"Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment","volume":"54","author":"Hwang","year":"2022","journal-title":"Nat Genet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01890-9","article-title":"Spatially resolved analysis of pancreatic cancer identifies therapy-associated remodeling of the tumor microenvironment","volume":"56","author":"Shiau","year":"2024","journal-title":"Nat Genet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36296-4","article-title":"Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment","volume":"14","author":"Werba","year":"2023","journal-title":"Nat Commun"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.10.001","article-title":"Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy","volume":"40","author":"Li","year":"2022","journal-title":"Cancer Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2026.218706","article-title":"Stress-adapted cancer-associated fibroblasts as mediators of immunosuppression and therapy resistance","volume":"657","author":"Hu","year":"2026","journal-title":"Cancer Lett"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.015","article-title":"Activated fibroblasts in cancer: Perspectives and challenges","volume":"41","author":"Caligiuri","year":"2023","journal-title":"Cancer Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.06.024","article-title":"Fibroblasts: Origins, definitions, and functions in health and disease","volume":"184","author":"Plikus","year":"2021","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.02.007","article-title":"Type I collagen deletion in \u03b1SMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J Exp Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05272-1","article-title":"LRRC15(+) myofibroblasts dictate the stromal setpoint to suppress tumour immunity","volume":"611","author":"Krishnamurty","year":"2022","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-23-0428","article-title":"Senescence defines a distinct subset of myofibroblasts that orchestrates immunosuppression in pancreatic cancer","volume":"14","author":"Belle","year":"2024","journal-title":"Cancer Discov"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50441-7","article-title":"Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8(+) T cell activation and limit responsiveness to immunotherapy in mice","volume":"15","author":"Assouline","year":"2024","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-23-3252","article-title":"Dissecting FAP+ cell diversity in pancreatic cancer uncovers an interferon-response subtype of cancer-associated fibroblasts with tumor-restraining properties","volume":"85","author":"Cumming","year":"2025","journal-title":"Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-335683","article-title":"Complement-secreting CAFs are associated with better prognosis in pancreatic cancer: single-cell multiomics","volume":"75","author":"Chen","year":"2026","journal-title":"Gut"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39762-1","article-title":"Cancer-associated fibroblast classification in single-cell and spatial proteomics data","volume":"14","author":"Cords","year":"2023","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.09.015","article-title":"Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin","volume":"40","author":"Foster","year":"2022","journal-title":"Cancer Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-18-0710","article-title":"IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.06.021","article-title":"Macropinocytosis maintains CAF subtype identity under metabolic stress in pancreatic cancer","volume":"43","author":"Zhang","year":"2025","journal-title":"Cancer Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-22-2316","article-title":"Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines","volume":"83","author":"Schw\u00f6rer","year":"2023","journal-title":"Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2024.01.022","article-title":"Rethinking the roles of cancer-associated fibroblasts in pancreatic cancer","volume":"17","author":"Francescone","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2020.05.004","article-title":"Differential contribution of pancreatic fibroblast subsets to the pancreatic cancer stroma","volume":"10","author":"Garcia","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34464-6","article-title":"The splanchnic mesenchyme is the tissue of origin for pancreatic fibroblasts during homeostasis and tumorigenesis","volume":"14","author":"Han","year":"2023","journal-title":"Nat Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.04.011","article-title":"Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer","volume":"40","author":"Huang","year":"2022","journal-title":"Cancer Cell"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.09.001","article-title":"Single-cell resolution spatial analysis of antigen-presenting cancer-associated fibroblast niches","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.06.017","article-title":"Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity","volume":"39","author":"Hutton","year":"2021","journal-title":"Cancer Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-21-0601","article-title":"Mesenchymal lineage heterogeneity underlies nonredundant functions of pancreatic cancer-associated fibroblasts","volume":"12","author":"Helms","year":"2022","journal-title":"Cancer Discov"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-20-3715","article-title":"Inhibition of Hedgehog signaling alters fibroblast composition in pancreatic cancer","volume":"27","author":"Steele","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-19-0958","article-title":"Regulatory T-cell depletion alters the tumor microenvironment and accelerates pancreatic carcinogenesis","volume":"10","author":"Zhang","year":"2020","journal-title":"Cancer Discov"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27607-8","article-title":"Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis","volume":"12","author":"Lee","year":"2021","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413432","article-title":"PPY-induced iCAFs cultivate an immunosuppressive microenvironment in pancreatic cancer","volume":"12","author":"Cao","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02237-6","article-title":"circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-\u03baB signaling pathway","volume":"41","author":"Zheng","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-20-1484","article-title":"Identification of functional heterogeneity of carcinoma-associated fibroblasts with distinct IL6-mediated therapy resistance in pancreatic cancer","volume":"12","author":"McAndrews","year":"2022","journal-title":"Cancer Discov"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57465-7","article-title":"Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response","volume":"16","author":"Song","year":"2025","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.03.004","article-title":"Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics","volume":"43","author":"Liu","year":"2025","journal-title":"Cancer Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-22-1046","article-title":"Cell-autonomous Cxcl1 sustains tolerogenic circuitries and stromal inflammation via neutrophil-derived TNF in pancreatic cancer","volume":"13","author":"Bianchi","year":"2023","journal-title":"Cancer Discov"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0683-3","article-title":"Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma","volume":"122","author":"De Jesus-Acosta","year":"2020","journal-title":"Br J Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54975-8","article-title":"Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer","volume":"15","author":"Veghini","year":"2024","journal-title":"Nat Commun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-24-0100","article-title":"Oncogenic KRAS-dependent stromal interleukin-33 directs the pancreatic microenvironment to promote tumor growth","volume":"14","author":"Donahue","year":"2024","journal-title":"Cancer Discov"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.01.003","article-title":"Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer","volume":"40","author":"Alam","year":"2022","journal-title":"Cancer Cell"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08426-5","article-title":"IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer","volume":"638","author":"Amisaki","year":"2025","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40314-w","article-title":"Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment","volume":"14","author":"Xue","year":"2023","journal-title":"Nat Commun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.06.011","article-title":"Oncogenic collagen I homotrimers from cancer cells bind to \u03b13\u03b21 integrin and impact tumor microbiome and immunity to promote pancreatic cancer","volume":"40","author":"Chen","year":"2022","journal-title":"Cancer Cell"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05169-z","article-title":"Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome","volume":"610","author":"Su","year":"2022","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22490-9","article-title":"Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells","volume":"12","author":"Tian","year":"2021","journal-title":"Nat Commun"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.00590","article-title":"Randomized phase III trial of pegvorhyaluronidase alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma","volume":"38","author":"Van Cutsem","year":"2020","journal-title":"J Clin Oncol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nature19084","article-title":"Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion","volume":"536","author":"Sousa","year":"2016","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-20-0119","article-title":"Macropinocytosis in cancer-associated fibroblasts is dependent on CaMKK2\/ARHGEF2 signaling and functions to support tumor and stromal cell fitness","volume":"11","author":"Zhang","year":"2021","journal-title":"Cancer Discov"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-20-0775","article-title":"Netrin G1 promotes pancreatic tumorigenesis through cancer-associated fibroblast-driven nutritional support and immunosuppression","volume":"11","author":"Francescone","year":"2021","journal-title":"Cancer Discov"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114972","article-title":"Cancer-associated fibroblasts maintain critical pancreatic cancer cell lipid homeostasis in the tumor microenvironment","volume":"43","author":"Han","year":"2024","journal-title":"Cell Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.163022","article-title":"Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer","volume":"8","author":"Kitamura","year":"2023","journal-title":"JCI Insight"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33991-6","article-title":"PD-L1-directed PlGF\/VEGF blockade synergizes with chemotherapy by targeting CD141(+) cancer-associated fibroblasts in pancreatic cancer","volume":"13","author":"Kim","year":"2022","journal-title":"Nat Commun"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.07.076","article-title":"Combined MEK and STAT3 inhibition uncovers stromal plasticity by enriching for cancer-associated fibroblasts with mesenchymal stem cell-like features to overcome immunotherapy resistance in pancreatic cancer","volume":"163","author":"Datta","year":"2022","journal-title":"Gastroenterology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.07.002","article-title":"KRAS(G12D) inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8(+) T cells","volume":"41","author":"Mahadevan","year":"2023","journal-title":"Cancer Cell"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-24-0177","article-title":"Mechanisms of resistance to oncogenic KRAS inhibition in pancreatic cancer","volume":"14","author":"Dilly","year":"2024","journal-title":"Cancer Discov"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-24-0740","article-title":"A classical epithelial state drives acute resistance to KRAS inhibition in pancreatic cancer","volume":"14","author":"Singhal","year":"2024","journal-title":"Cancer Discov"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-022-00582-0","article-title":"Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix","volume":"4","author":"Kay","year":"2022","journal-title":"Nat Metab"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1172\/jci146987","article-title":"Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts","volume":"131","author":"Bhattacharjee","year":"2021","journal-title":"J Clin Invest"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl1197","article-title":"Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response","volume":"10","author":"Pereira","year":"2024","journal-title":"Sci Adv"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.113012","article-title":"Primary and metastatic cellular landscapes in human pancreatic cancer","volume":"28","author":"Steele","year":"2025","journal-title":"iScience"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08927-x","article-title":"Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer","volume":"642","author":"Pei","year":"2025","journal-title":"Nature"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-23-1660","article-title":"Transfer learning reveals cancer-associated fibroblasts are associated with epithelial-mesenchymal transition and inflammation in cancer cells in pancreatic ductal adenocarcinoma","volume":"84","author":"Guinn","year":"2024","journal-title":"Cancer Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00463-1","article-title":"Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells","volume":"3","author":"Halbrook","year":"2022","journal-title":"Nat Cancer"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-25-0331","article-title":"Cancer-associated fibroblasts promote epithelial-mesenchymal transition and classical to basal subtype shift in pancreatic cancer","volume":"86","author":"Belanger","year":"2026","journal-title":"Cancer Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-026-01938-4","article-title":"Cancer-associated fibroblasts regulate DNA repair in pancreatic cancer through NDRG1-mediated R-loop processing","volume":"28","author":"Kozlova","year":"2026","journal-title":"Nat Cell Biol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-19-0454","article-title":"Meflin-positive cancer-associated fibroblasts inhibit pancreatic carcinogenesis","volume":"79","author":"Mizutani","year":"2019","journal-title":"Cancer Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-24-4707","article-title":"Estrogen production in pancreatic cancer shapes a tumor-suppressive stromal microenvironment","volume":"86","author":"Manoukian","year":"2026","journal-title":"Cancer Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06087-8","article-title":"Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions","volume":"7","author":"Boelaars","year":"2024","journal-title":"Commun Biol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.02.024","article-title":"Stromal HIF2 regulates immune suppression in the pancreatic cancer microenvironment","volume":"162","author":"Garcia Garcia","year":"2022","journal-title":"Gastroenterology"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01579-x","article-title":"Fibrosis induced by resident macrophages has divergent roles in pancreas inflammatory injury and PDAC","volume":"24","author":"Baer","year":"2023","journal-title":"Nat Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002876","article-title":"Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer","volume":"9","author":"Carbone","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2023.2300913","article-title":"Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance","volume":"20","author":"Zhang","year":"2024","journal-title":"Autophagy"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.495","article-title":"\u03b1-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study","volume":"111","author":"Sinn","year":"2014","journal-title":"Br J Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101248","article-title":"Desmoplastic stromal signatures predict patient outcomes in pancreatic ductal adenocarcinoma","volume":"4","author":"Mascharak","year":"2023","journal-title":"Cell Rep Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000006416","article-title":"Tumor-intrinsic and cancer-associated fibroblast subtypes independently predict outcomes in pancreatic cancer","volume":"280","author":"Lee","year":"2024","journal-title":"Ann Surg"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.86125","article-title":"Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma","volume":"12","author":"Croft","year":"2023","journal-title":"Elife"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2026.102946","article-title":"Histology-derived prediction of a stromal remodeling program in pancreatic ductal adenocarcinoma with transcriptomic and spatial validation","volume":"72","author":"Bao","year":"2026","journal-title":"Transl Oncol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43495-y","article-title":"Cancer-associated fibroblast-related prognostic signature predicts prognosis and immunotherapy response in pancreatic adenocarcinoma based on single-cell and bulk RNA-sequencing","volume":"13","author":"Chen","year":"2023","journal-title":"Sci Rep"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02519-7","article-title":"Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system","volume":"41","author":"Schuth","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-026-01165-8","article-title":"Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial","volume":"7","author":"Perez","year":"2026","journal-title":"Nat Cancer"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-022-01650-9","article-title":"CODA: quantitative 3D reconstruction of large tissues at cellular resolution","volume":"19","author":"Kiemen","year":"2022","journal-title":"Nat Methods"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2025.101261","article-title":"Combining spatial transcriptomics and ECM imaging in 3D for mapping cellular interactions in the tumor microenvironment","volume":"16","author":"Pentimalli","year":"2025","journal-title":"Cell Syst"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.11.044","article-title":"Cadherin 11 promotes immunosuppression and extracellular matrix deposition to support growth of pancreatic tumors and resistance to gemcitabine in mice","volume":"160","author":"Peran","year":"2021","journal-title":"Gastroenterology"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-022-02253-6","article-title":"Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair","volume":"41","author":"Zhang","year":"2022","journal-title":"Oncogene"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211631","article-title":"CCR2\/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma","volume":"219","author":"Wang","year":"2022","journal-title":"J Exp Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-23-2504","article-title":"The extracellular niche and tumor microenvironment enhance KRAS inhibitor efficacy in pancreatic cancer","volume":"84","author":"Kumarasamy","year":"2024","journal-title":"Cancer Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.08.007","article-title":"Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy","volume":"159","author":"Sherman","year":"2014","journal-title":"Cell"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-022-02288-9","article-title":"Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics","volume":"41","author":"Iida","year":"2022","journal-title":"Oncogene"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14512-2","article-title":"Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemcitabine and NAB-paclitaxel therapy in advanced pancreatic cancer","volume":"26","author":"Easty","year":"2026","journal-title":"BMC Cancer"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2026.06.001","article-title":"Molecular phenotypes and spatial archetypes: a new framework for cancer-associated fibroblasts","volume":"44","author":"Liu","year":"2026","journal-title":"Cancer Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1971880\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:17:03Z","timestamp":1791285423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1971880\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":94,"alternative-id":["10.3389\/fimmu.2026.1971880"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1971880","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"article-number":"1971880"}}